Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE)
Clinical trial NCT04394351 · COMPLETED
Trial details
- NCT number
- NCT04394351
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2022-06-02
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.